Patient Management

Non-alcoholic fatty liver disease (NAFLD) and its progressive form, non-alcoholic steatohepatitis (NASH), are highly prevalent in Italy, with significant variation across regions....

Patient Management Guidelines

Guidance From Medscape

Expert opinions, case studies, quizzes, and more can be found at Medscape’s new portal for clinicians who treat metabolic dysfunction-associated steatotic liver disease and metabolic dysfunction-associated steatohepatitis.

Managing Metabolic Dysfunction-associated Steatotic Liver and Metabolic Dysfunction-associated Steatohepatitis

The Journal of Hepatology provides detailed information for clinicians who treat patients who have been diagnosed with liver diseases formerly known as nonalcoholic steatohepatitis (NASH).

American Association for the Study of Liver Diseases (AASLD) Guidelines

AASLD offers guidelines that are current and revised regularly by a committee of experts in the field of hepatology.

Articles

Intermittent Fasting Is an Effective Way to Reverse Fatty Liver Disease

In an interview with the Fatty Liver Alliance, Dr. Jason Fung, a nephrologist, bestselling author, and co-founder of The Fasting...
Jennifer Geremia,
CURATED BY:
Jennifer Geremia,
MSPAS, PA-C

Bariatric Surgery Lowers Mortality and Heart Risk in MASLD Better Than Medications

A recent multicenter study of more than 8,600 patients with metabolic dysfunction-associated steatotic liver disease (MASLD) found that bariatric surgery...
Jennifer Geremia,
CURATED BY:
Jennifer Geremia,
MSPAS, PA-C

Recommending Non-invasive Liver Disease Assessments

Chronic liver disease (CLD) causes approximately two million deaths annually and presents a major global health burden. Because most severe...
Corrie Berk,
CURATED BY:
Corrie Berk,
DNP, MBA, APRN

Systemic Impacts of MASLD on Heart-related Diseases

This review provided a comprehensive analysis of the extrahepatic manifestations of metabolic dysfunction-associated steatohepatitis (MASH), focusing on chronic diseases related...
Chantil D. Jeffreys,
CURATED BY:
Chantil D. Jeffreys,
FNP, DNP, JD

Challenges of Liver Transplantation for MASLD

Liver transplantation (LT) for metabolic dysfunction-associated steatotic liver disease (MASLD) is challenging due to high comorbidity rates, including obesity, diabetes,...
Jennifer Geremia,
CURATED BY:
Jennifer Geremia,
MSPAS, PA-C

Genetic Risk Factors for NASH-Related Hepatocellular Carcinoma

This study aimed to identify genetic risk factors driving the progression from non-alcoholic fatty liver disease (NAFLD) to non-alcoholic steatohepatitis...
Jennifer Geremia,
CURATED BY:
Jennifer Geremia,
MSPAS, PA-C
Share